Navigation Links
Porter Novelli Named Agency of Record for Prix Galien USA Awards
Date:6/29/2011

NEW YORK, June 29, 2011 /PRNewswire/ -- Global public relations leader Porter Novelli today announced that it has been named agency of record for the Prix Galien USA Awards, which recognize excellence in biopharmaceutical research and development that has significantly improved the human condition. Porter Novelli will be responsible for raising awareness of the award in the U.S. and driving volume of submissions.

The Prix Galien is internationally renowned for recognizing the development of innovative medicines and medical technologies. Judged by a prestigious committee of scientists and clinicians, the Prix Galien is considered the industry's highest accolade. The awards are presented in the following categories, in which one to three prizes are given: Best Pharmaceutical Agent, Best Biotechnical Product and Best Medical Device.

"Innovation in medicine is something that needs to be nurtured, acknowledged and rewarded," said Susan Hayes, global director, health, Porter Novelli. "Porter Novelli is pleased to support the Prix Galien's commitment to progress in health and medicine, a goal that everyone in the health care community shares."

The Prix Galien USA award committee comprises 11 individuals including Nobel Laureates, founders of major biotech companies and editors of world-renowned biology journals. The 2011 Prix Galien USA Awards will be held on September 27, 2011 at the American Museum of Natural History in New York City.

As part of the events that take place around the awards, Peter Pitts, director of global regulatory and health policy at Porter Novelli, will participate in the panel discussion, "What is 'Value' and How Can it be Measured and Demonstrated in Therapeutic Innovations? Breaking Down the Barriers of the Past."

About Porter Novelli

A global public relations leader, Porter Novelli was founded in 1972 and is a part of Omnicom Group Inc. (NYSE: OMC). In 90 offices in nearly 60 countries, Porter Novelli combines the power of immersion with the rigor of research to create deep human insights that enable the agency to transform the opinions, beliefs and behaviors of those who matter most to its clients. For additional information, please visit www.porternovelli.com.

Contact:
Catherine Sullivan
Catherine.Sullivan@porternovelli.com
212-601-8315


'/>"/>
SOURCE Porter Novelli
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds India Medical Devices Manufacturers, Distributors and Exporters Directory 2011
2. PharMEDium Becomes a Corporate Supporter of the American Society of Anesthesiologists (ASA)
3. Merrimack Pharmaceuticals Announces the Addition of Michael Porter to its Board of Directors
4. Michael Porter, Janet Woodcock, Peter Senge Among Speakers at Inaugural Innovation in Healthcare Symposium
5. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
6. Bend Research Named Large Distinguished Business of the Year by Bend Chamber of Commerce Membership
7. Cepheid CEO John Bishop Named Ernst & Young Entrepreneur Of The Year® 2011 Northern California Award winner
8. Dr. Jay Yadav, CardioMEMS Founder & CEO, Named Ernst & Young Entrepreneur of the Year®
9. Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System
10. Robert Kline, President & CEO, Medivance Named Ernst & Young Entrepreneur Of The Year® 2011 Regional Award Winner
11. AlphaDetail, Healthcare Market Research Specialist, Named to the Honomichl Top 50
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... May 23, 2016 Non-invasive diagnostic ... of multiple diseases; ,Technology to be presented at Yissum’s ... Yissum Research Development Company of the Hebrew University of ... research agreement with Aurum Ventures MKI, the technology investment arm ... a new diagnostic approach for early detection of multiple ...
(Date:5/23/2016)... May 23, 2016 Gamida Cell, ... treatment of cancer and orphan genetic diseases, announced today ... $4.4 million from the Israel Innovation Authority (formerly the ... of Economy and Industry. The mission of the Israel ... various industries, including science and technology, while stimulating economic ...
(Date:5/23/2016)... 2016   Purdue Pharma L.P.  today announced ... with Egalet Corporation and Acura Pharmaceuticals, Inc. that ... the agreement the companies will exchange valuable patent ... companies to develop and sell several opioid pain ... reflects the commitment of Purdue Pharma to seek ...
Breaking Medicine Technology:
(Date:5/24/2016)... Indianapolis, IN (PRWEB) , ... May 24, 2016 ... ... employee benefits advisory organization, is pleased to welcome new Partner Firm Austin & ... a personalized, consultative approach to insurance, employee benefits, HR consulting, benefits technology, and ...
(Date:5/24/2016)... ... May 24, 2016 , ... New Brunswick, New Jersey: This year ... needs reach their fullest potential. To commemorate the anniversary, the hospital has themed the ... n’ Roll for Children’s Specialized Hospital Foundation on Saturday, May 21, at Johnson Park ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... ... for physical disease or injury that focuses on repairing the musculoskeletal and neuromuscular ... With an emphasis on functional restoration, NYDNRehab began providing treatments for physical therapy ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Growing in popularity, ... trend, more gluten-free products are available and easily accessible. Whether someone chooses to cut ... cater to a certain diet, King Kullen Grocery stocks their shelves with many different ...
(Date:5/24/2016)... OR (PRWEB) , ... May 24, 2016 , ... ... welcomed Peggy Kinst, a wellness specialist for forty years and a trainer for ... the Sharon Kleyne Hour Radio Talk Show on May 16, 2016. , Formerly ...
Breaking Medicine News(10 mins):